Home.md
... ...
@@ -203,8 +203,8 @@ MZL, MZL-exome, 21
203 203
MZL-exome, Rossi 2012, 21
204 204
MZL, MZL-exome, 7
205 205
MZL-exome, Parry 2013, 7
206
-PMBL, PMBL-Sanger, 2
207
-PMBL-Sanger, Weniger 2006, 2
206
+PMBL Sanger, Weniger 2006, 2
207
+PMBL, PMBL Sanger, 2
208 208
Tiacci 2018, PMBL Tier 1, 1
209 209
Tiacci 2018, PMBL Tier 2, 9
210 210
Duns 2021, PMBL Tier 1, 5
... ...
@@ -225,25 +225,26 @@ Sarkozy 2021, PMBL Tier 2, 6
225 225
Mottok 2019, PMBL Tier 1, 6
226 226
Mottok 2019, PMBL Tier 2, 15
227 227
PMBL, PMBL-exome, 13
228
-PMBL-exome, Duns 2021, 13
228
+
229 229
PMBL, PMBL-exome, 10
230
-PMBL-exome, Tiacci 2018, 10
230
+
231 231
PMBL, PMBL-panel, 10
232
-PMBL-panel, Desch 2020, 10
233 232
PMBL, PMBL-exome, 7
234
-PMBL-exome, Gomez 2023, 7
235
-
236 233
PMBL, PMBL-exome, 7
237
-PMBL-exome, Wienand 2019, 7
238 234
PMBL, PMBL-exome, 29
235
+PMBL, PMBL-exome, 11
236
+PMBL, PMBL-exome, 21
237
+PMBL-exome, Gomez 2023, 7
238
+PMBL-exome, Wienand 2019, 7
239 239
PMBL-exome, Reichel 2015, 29
240 240
PMBL, PMBL-Array/Sanger, 2
241 241
PMBL-Array/Sanger, Otto 2012, 2
242
-PMBL, PMBL-exome, 11
243 242
PMBL-exome, Sarkozy 2021, 11
244
-PMBL, PMBL-exome, 21
245
-PMBL-exome, Mottok 2019, 21
246 243
244
+PMBL-exome, Mottok 2019, 21
245
+PMBL-exome, Tiacci 2018, 10
246
+PMBL-exome, Duns 2021, 13
247
+PMBL-panel, Desch 2020, 10
247 248
```
248 249
249 250
## B-cell Lymphoma aSHM targets